Template:Congestive heart failure: Difference between revisions

	Congestive Heart Failure Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology Systolic Dysfunction Diastolic Dysfunction HFpEF HFrEF
Causes
Differentiating Congestive heart failure from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Clinical Assessment
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Cardiac MRI
Echocardiography
Exercise Stress Test
Myocardial Viability Studies
Cardiac Catheterization
Other Imaging Studies
Other Diagnostic Studies
Treatment
Invasive Hemodynamic Monitoring
Medical Therapy:
Summary
Acute Pharmacotherapy
Chronic Pharmacotherapy in HFpEF
Chronic Pharmacotherapy in HFrEF Diuretics ACE Inhibitors Angiotensin receptor blockers Aldosterone Antagonists Beta Blockers Ca Channel Blockers Nitrates Hydralazine Positive Inotropics Anticoagulants Angiotensin Receptor-Neprilysin Inhibitor Antiarrhythmic Drugs Nutritional Supplements Hormonal Therapies Drugs to Avoid Drug Interactions Treatment of underlying causes Associated conditions
Exercise Training
Surgical Therapy: Biventricular Pacing or Cardiac Resynchronization Therapy (CRT) Implantation of Intracardiac Defibrillator Ultrafiltration Cardiac Surgery Left Ventricular Assist Devices (LVADs) Cardiac Transplantation
ACC/AHA Guideline Recommendations Initial and Serial Evaluation of the HF Patient Hospitalized Patient Patients With a Prior MI Sudden Cardiac Death Prevention Surgical/Percutaneous/Transcather Interventional Treatments of HF Patients at high risk for developing heart failure (Stage A) Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B) Patients with current or prior symptoms of heart failure (Stage C) Patients with refractory end-stage heart failure (Stage D) Coordinating Care for Patients With Chronic HF Quality Metrics/Performance Measures
Implementation of Practice Guidelines
Congestive heart failure end-of-life considerations
Specific Groups: Special Populations Patients who have concomitant disorders Obstructive Sleep Apnea in the Patient with CHF NSTEMI with Heart Failure and Cardiogenic Shock
Congestive heart failure On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Congestive heart failure
CDC on Congestive heart failure
Congestive heart failure in the news
Blogs on Congestive heart failure
Directions to Hospitals Treating Congestive heart failure
Risk calculators and risk factors for Congestive heart failure

VisualWikitext

Template:Congestive heart failure: Difference between revisions

Latest revision as of 17:06, 23 December 2019

Navigation menu

@@ Line 1: / Line 1: @@
-{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
+{| class="infobox bordered" style="width:15%; text-align:left; font-size:90%; background:AliceBlue"
 |-
-| colspan="1" style="text-align:center; background:DarkGray" |
+| colspan="1" style="text-align:center; background:DarkGray" |'''Congestive Heart Failure Microchapters'''
-'''Congestive heart failure Microchapters
-'''
 |- bgcolor="LightGrey"
 !
@@ Line 16: / Line 15: @@
 |- bgcolor="Pink"
 !
-[[Congestive heart failure (patient information)|Patient Info]]
+[[Congestive heart failure (patient information)|Patient Information]]
 |-
 !
@@ Line 28: / Line 27: @@
 |- bgcolor="Pink"
 !
-[[Congestive heart failure pathophysiology|Pathophysiology]]
+[[Congestive heart failure historical perspective|Historical Perspective]]
 |-
 !
@@ Line 34: / Line 33: @@
 |- bgcolor="Pink"
 !
-[[Congestive heart failure etiology|Etiology]]
+[[Congestive heart failure classification|Classification]]
 |-
 !
@@ Line 40: / Line 39: @@
 |- bgcolor="Pink"
 !
-[[Congestive heart failure epidemiology and demographics|Epidemiology & Demographics]]
+Pathophysiology
+:[[Congestive heart failure pathophysiology#Systolic dysfunction|Systolic Dysfunction]]
+:[[Diastolic dysfunction pathophysiology|Diastolic Dysfunction]]
+:[[Congestive heart failure with preserved EF|HFpEF]]
+:[[Congestive heart failure with reduced EF|HFrEF]]
 |-
 !
@@ Line 46: / Line 49: @@
 |- bgcolor="Pink"
 !
-[[Congestive heart failure risk factors|Risk Factors]]
+[[Congestive heart failure causes|Causes]]
+|-
+!
+|- bgcolor="Pink"
+!
+[[Congestive heart failure differential diagnosis|Differentiating Congestive heart failure from other Diseases]]
 |-
 !
@@ Line 52: / Line 61: @@
 |- bgcolor="Pink"
 !
-[[Congestive heart failure screening|Screening]]
+[[Congestive heart failure epidemiology and demographics|Epidemiology and Demographics]]
 |-
 !
@@ Line 58: / Line 67: @@
 |- bgcolor="Pink"
 !
-[[Congestive heart failure natural history|Natural History, Complications & Prognosis]]
+[[Congestive heart failure risk factors|Risk Factors]]
 |-
 !
@@ Line 64: / Line 73: @@
 |- bgcolor="Pink"
 !
-[[Congestive heart failure causes|Causes of Congestive heart failure]]
+[[Congestive heart failure Screening|Screening]]
 |-
 !
@@ Line 70: / Line 79: @@
 |- bgcolor="Pink"
 !
-[[Congestive heart failure differential diagnosis|Differentiating Congestive heart failure from other Diseases]]
+[[Congestive heart failure natural history|Natural History, Complications and Prognosis]]
 |-
 !
@@ Line 82: / Line 91: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Congestive heart failure history and symptoms|History & Symptoms]]
+[[Congestive heart failure clinical assessment|Clinical Assessment]]
+|-
+!
+|- bgcolor="LightSkyBlue"
+!
+[[Congestive heart failure history and symptoms|History and Symptoms]]
 |-
 !
@@ Line 94: / Line 109: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Congestive heart failure laboratory tests|Lab Tests]]
+[[Congestive heart failure laboratory tests|Laboratory Findings]]
 |-
 !
@@ Line 112: / Line 127: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Congestive heart failure MRI|MRI]]
+[[Congestive heart failure cardiac MRI|Cardiac MRI]]
 |-
 !
@@ Line 118: / Line 133: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Congestive heart failure CT|CT]]
+[[Congestive heart failure echocardiography|Echocardiography]]
 |-
 !
@@ Line 124: / Line 139: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Congestive heart failure echocardiography or ultrasound|Echocardiography or Ultrasound]]
+[[Congestive heart failure exercise stress testing|Exercise Stress Test]]
 |-
 !
@@ Line 130: / Line 145: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Congestive heart failure other imaging findings|Other Imaging Findings]]
+[[Congestive heart failure myocardial viability study|Myocardial Viability Studies]]
+|-
+!
+|- bgcolor="LightSkyBlue"
+!
+[[Congestive heart failure cardiac catheterization|Cardiac Catheterization]]
+|-
+!
+|- bgcolor="LightSkyBlue"
+!
+[[Congestive heart failure Other Imaging Studies|Other Imaging Studies]]
 |-
 !
@@ Line 148: / Line 175: @@
 |- bgcolor="PaleTurquoise"
 !
-[[Congestive heart failure medical therapy|Medical Therapy]]
+[[Congestive heart failure invasive monitoring|Invasive Hemodynamic Monitoring]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+Medical Therapy:
+|- bgcolor="PaleTurquoise"
+!
+: [[Congestive heart failure pharmacotherapy|Summary]]
+|- bgcolor="PaleTurquoise"
+!
+: [[Congestive heart failure acute pharmacotherapy|Acute Pharmacotherapy]]
+|- bgcolor="PaleTurquoise"
+!
+: [[Congestive heart failure with preserved EF pharmacotherapy|Chronic Pharmacotherapy in HFpEF]]
+|- bgcolor="PaleTurquoise"
+!
+: [[Congestive heart failure chronic pharmacotherapy|Chronic Pharmacotherapy in HFrEF]]
+:: [[Congestive heart failure diuretics|Diuretics]]
+:: [[Congestive heart failure ACE inhibitors|ACE Inhibitors]]
+:: [[Congestive heart failure angiotensin receptor blockers|Angiotensin receptor blockers]]
+:: [[Congestive heart failure aldosterone antagonists|Aldosterone Antagonists]]
+:: [[Congestive heart failure beta blockers|Beta Blockers]]
+:: [[Congestive heart failure calcium channel blockers|Ca Channel Blockers]]
+:: [[Congestive heart failure vasodilators|Nitrates]]
+:: [[Congestive heart failure vasodilators|Hydralazine]]
+:: [[Congestive heart failure positive inotropics|Positive Inotropics]]
+:: [[Congestive heart failure anticoagulants|Anticoagulants]]
+:: [[Congestive heart failure angiotensin receptor-neprilysin inhibitor|Angiotensin Receptor-Neprilysin Inhibitor]]
+:: [[Congestive heart failure antiarrhythmic Drugs|Antiarrhythmic Drugs]]
+:: [[Congestive heart failure other pharmacotherapies#Nutritional Supplements|Nutritional Supplements]]
+:: [[Congestive heart failure other pharmacotherapies#Hormonal Therapies|Hormonal Therapies]]
+:[[Congestive heart failure drugs to avoid|Drugs to Avoid]]
+:[[Congestive heart failure drug interactions|Drug Interactions]]
+:[[Congestive heart failure treatment of underlying causes|Treatment of underlying causes]]
+:[[Congestive heart failure treatment of associated conditions|Associated conditions]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[Congestive heart failure and exercise|Exercise Training]]
 |-
 !
@@ Line 154: / Line 223: @@
 |- bgcolor="PaleTurquoise"
 !
-[[Congestive heart failure surgery|Surgery]]
+Surgical Therapy:
+: [[Congestive heart failure biventricular pacing or cardiac resynchronization therapy|Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)]]
+: [[Congestive heart failure implantation of intracardiac defibrillator|Implantation of Intracardiac Defibrillator]]
+: [[Congestive heart failure ultrafiltration|Ultrafiltration]]
+: [[Congestive heart failure cardiac surgery|Cardiac Surgery]]
+: [[Congestive heart failure left ventricular assist devices|Left Ventricular Assist Devices (LVADs)]]
+: [[Congestive heart failure cardiac transplantation|Cardiac Transplantation]]
 |-
 !
@@ Line 160: / Line 235: @@
 |- bgcolor="PaleTurquoise"
 !
-[[Congestive heart failure primary prevention|Primary Prevention]]
+ACC/AHA Guideline Recommendations
+: [[Congestive heart failure AHA recommendations|Initial and Serial Evaluation of the HF Patient]]
+: [[Congestive heart failure AHA recommendations for hospitalized patient|Hospitalized Patient]]
+: [[Congestive heart failure AHA recommendations for patients with a prior MI|Patients With a Prior MI]]
+: [[Congestive heart failure sudden cardiac death prevention|Sudden Cardiac Death Prevention]]
+: [[Congestive heart failure AHA recommendations Surgical/Percutaneous/Transcather Interventional Treatments of HF|Surgical/Percutaneous/Transcather Interventional Treatments of HF]]
+: [[Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)|Patients at high risk for developing heart failure (Stage A)]]
+: [[Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)|Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)]]
+: [[Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)|Patients with current or prior symptoms of heart failure (Stage C)]]
+: [[Congestive heart failure treatment of patients with refractory end-stage heart failure (Stage D)|Patients with refractory end-stage heart failure (Stage D)]]
+: [[Congestive heart failure AHA recommendations Coordinating Care for Patients With Chronic HF|Coordinating Care for Patients With Chronic HF]]
+: [[Congestive heart failure AHA recommendations Quality Metrics/Performance Measures|Quality Metrics/Performance Measures]]
 |-
 !
 |- bgcolor="PaleTurquoise"
 !
-[[Congestive heart failure secondary prevention|Secondary Prevention]]
+[[Congestive heart failure implementation of practice guidelines|Implementation of Practice Guidelines]]
 |-
 !
 |- bgcolor="PaleTurquoise"
 !
-[[Congestive heart failure cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
+[[Congestive heart failure end-of-life considerations|Congestive heart failure end-of-life considerations]]
 |-
 !
 |- bgcolor="PaleTurquoise"
 !
-[[Congestive heart failure future or investigational therapies|Future or Investigational Therapies]]
+Specific Groups:
+: [[Congestive heart failure treatment of special populations|Special Populations]]
+: [[Congestive heart failure treatment of patients who have concomitant disorders|Patients who have concomitant disorders]]
+: [[Congestive heart failure and obstructive sleep apnea|Obstructive Sleep Apnea in the Patient with CHF]]
+: [[Unstable angina / non ST elevation myocardial infarction Heart Failure and Cardiogenic Shock|NSTEMI with Heart Failure and Cardiogenic Shock]]
 |-
 !
 |- bgcolor="PaleGoldenrod "
@@ Line 262: / Line 352: @@
 |- bgcolor="LightYellow"
 !
-[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small>
+[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]
 |-
 !
@@ Line 278: / Line 368: @@
 !
+|-
 |}